Upadacitinib as a Novel Treatment in Therapy Refractory Collagenous Colitis.

Journal Article Corrected proof Upadacitinib as a Novel Treatment in Therapy Refractory Collagenous Colitis Get access Leo Boneschansker, MD, PhD, Leo Boneschansker, MD, PhD Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Kristin E Burke, MD, MPH Kristin E Burke, MD, MPH Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA Address correspondence to: Kristin E. Burke, Massachusetts General Hospital Crohn’s and Colitis Center, 165 Cambridge Street, Boston, MA 02114, USA (keburke@mgh.harvard.edu). https://orcid.org/0000-0002-2536-5538 Search for other works by this author on: Oxford Academic PubMed Google Scholar Inflammatory Bowel Diseases, izad085, https://doi.org/10.1093/ibd/izad085 Published: 17 May 2023 Article history Received: 31 March 2023 Editorial decision: 11 April 2023 Corrected and typeset: 17 May 2023 Published: 17 May 2023